IRIS Accounts Production v24.2.0.383 11925469 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false false true false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh119254692023-04-30119254692024-04-30119254692023-05-012024-04-30119254692022-04-30119254692022-05-012023-04-30119254692023-04-3011925469ns15:EnglandWales2023-05-012024-04-3011925469ns14:PoundSterling2023-05-012024-04-3011925469ns10:Director12023-05-012024-04-3011925469ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3011925469ns10:SmallEntities2023-05-012024-04-3011925469ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3011925469ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3011925469ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3011925469ns10:FullAccounts2023-05-012024-04-301192546912023-05-012024-04-3011925469ns10:OrdinaryShareClass12023-05-012024-04-3011925469ns10:Director32023-05-012024-04-3011925469ns10:Director42023-05-012024-04-3011925469ns10:Director52023-05-012024-04-3011925469ns10:Director82023-05-012024-04-3011925469ns10:Director112023-05-012024-04-3011925469ns10:RegisteredOffice2023-05-012024-04-3011925469ns5:CurrentFinancialInstruments2024-04-3011925469ns5:CurrentFinancialInstruments2023-04-3011925469ns5:Non-currentFinancialInstruments2024-04-3011925469ns5:Non-currentFinancialInstruments2023-04-3011925469ns5:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3011925469ns5:PatentsTrademarksLicencesConcessionsSimilar2023-05-012024-04-3011925469ns5:PlantMachinery2023-05-012024-04-3011925469ns5:IntangibleAssetsOtherThanGoodwill2023-04-3011925469ns5:IntangibleAssetsOtherThanGoodwill2024-04-3011925469ns5:IntangibleAssetsOtherThanGoodwill2023-04-3011925469ns5:PlantMachinery2023-04-3011925469ns5:PlantMachinery2024-04-3011925469ns5:PlantMachinery2023-04-3011925469ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-04-3011925469ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-05-012024-04-3011925469ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-04-3011925469ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-04-3011925469ns5:CostValuation2023-04-3011925469ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-04-3011925469ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-3011925469ns5:CurrentFinancialInstruments2023-05-012024-04-3011925469ns10:OrdinaryShareClass12024-04-30
REGISTERED NUMBER: 11925469 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH APRIL 2024

FOR

REGENALL LIMITED

REGENALL LIMITED (REGISTERED NUMBER: 11925469)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH APRIL 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


REGENALL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30TH APRIL 2024







DIRECTORS: Mr. W Buchanan
Ms. N K C Horlick
Professor C B D Lavy
Mr. H M H Noordeen
Mr R D L P Beresford
Professor R Smith





REGISTERED OFFICE: 19 Harley Street
London
W1G 9QJ





REGISTERED NUMBER: 11925469 (England and Wales)






REGENALL LIMITED (REGISTERED NUMBER: 11925469)

BALANCE SHEET
30TH APRIL 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 187,745 217,033
Tangible assets 5 40,055 47,123
Investments 6 1,507 1,507
229,307 265,663

CURRENT ASSETS
Debtors 7 32,269 53,029
Cash at bank 59 597
32,328 53,626
CREDITORS
Amounts falling due within one year 8 1,012,330 406,499
NET CURRENT LIABILITIES (980,002 ) (352,873 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(750,695

)

(87,210

)

CREDITORS
Amounts falling due after more than one year 9 100,000 104,228
NET LIABILITIES (850,695 ) (191,438 )

CAPITAL AND RESERVES
Called up share capital 10 14,945 14,911
Share premium 1,215,066 1,130,100
Retained earnings (2,080,706 ) (1,336,449 )
SHAREHOLDERS' FUNDS (850,695 ) (191,438 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11th October 2024 and were signed on its behalf by:



Mr. H M H Noordeen - Director


REGENALL LIMITED (REGISTERED NUMBER: 11925469)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH APRIL 2024


1. STATUTORY INFORMATION

Regenall Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc - 15% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

REGENALL LIMITED (REGISTERED NUMBER: 11925469)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH APRIL 2024


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1st May 2023
and 30th April 2024 292,883
AMORTISATION
At 1st May 2023 75,850
Charge for year 29,288
At 30th April 2024 105,138
NET BOOK VALUE
At 30th April 2024 187,745
At 30th April 2023 217,033

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1st May 2023 74,418
At 30th April 2024 74,418
DEPRECIATION
At 1st May 2023 27,295
Charge for year 7,068
At 30th April 2024 34,363
NET BOOK VALUE
At 30th April 2024 40,055
At 30th April 2023 47,123

REGENALL LIMITED (REGISTERED NUMBER: 11925469)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH APRIL 2024


5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1st May 2023
and 30th April 2024 52,108
DEPRECIATION
At 1st May 2023 14,460
Charge for year 5,647
At 30th April 2024 20,107
NET BOOK VALUE
At 30th April 2024 32,001
At 30th April 2023 37,648

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1st May 2023
and 30th April 2024 1,507
NET BOOK VALUE
At 30th April 2024 1,507
At 30th April 2023 1,507

The company has the following unpaid investments in subsidiaries at year end.

-Regenall Phytoceutical Limited (incorporated on 10/08/2021) - 50,000 of 100,000 ordinary shares at £0.01 - £500
-Serendipity Animal Health Limited (incorporated on 11/03/2021; DISSOLVED on 17/10/2023) - 735 of 1000 ordinary shares at £0.01 - £7.35
-Regenall Cosmetics Limited (incorporated on 22/03/2021; DISSOLVED on 17/10/2023) - 1 of 2 ordinary shares at £0.01 - £0.01
-Regenall Equine Health Solutions Limited (incorporated on 08/11/2022) - 100,000 of 100,000 ordinary shares at £.01 - £1,000

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 32,269 53,029

REGENALL LIMITED (REGISTERED NUMBER: 11925469)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH APRIL 2024


8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Hire purchase contracts 4,228 18,936
Trade creditors 239,027 106,183
Taxation and social security 37,557 9,027
Other creditors 731,518 272,353
1,012,330 406,499

Included in the Other creditors figure are the following:

- A company with a common director/shareholder had a total receivable of £315,729 (2023: £118,772) from Regenall Limited as at 30th April 2024. This balance is interest free and unsecured.

-As at 30th April 2024 there was a balance of £384,431 (2023:£146,574) due to a director/shareholder of Regenall Limited.

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Hire purchase contracts - 4,228
Other creditors 100,000 100,000
100,000 104,228

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1,494,486 Ordinary £0.01 14,945 14,911

11. RELATED PARTY DISCLOSURES

- Polo Breeding Limited a company raising horses and other equines had trading of £15,500 with Regenall Limited during the year. Regenall Limited and Polo Breeding Limited have common shareholders.

- A company with a common director/shareholder had a total receivable of £315,729 (2023: £118,772) from Regenall Limited as at 30th April 2024. This balance is interest free and unsecured.

-As at 30th April 2024 there was a balance of £384,431 (2023:£146,574) due to a director/shareholder of Regenall Limited.